Is CC or ASIX more profitable?

AdvanSix has a net margin of -1.14% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -5.00% 60.64% 1.48% AdvanSix -1.14% -1.28% -0.61%

Does the media prefer CC or ASIX?

In the previous week, Chemours had 16 more articles in the media than AdvanSix. MarketBeat recorded 19 mentions for Chemours and 3 mentions for AdvanSix. Chemours' average media sentiment score of 0.47 beat AdvanSix's score of 0.11 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral AdvanSix 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor EMN or CC?

In the previous week, Chemours had 1 more articles in the media than Eastman Chemical. MarketBeat recorded 19 mentions for Chemours and 18 mentions for Eastman Chemical. Eastman Chemical's average media sentiment score of 0.75 beat Chemours' score of 0.47 indicating that Eastman Chemical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eastman Chemical 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Is HUN or CC more profitable?

Huntsman has a net margin of -3.05% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Huntsman's return on equity. Company Net Margins Return on Equity Return on Assets Huntsman -3.05% -3.49% -1.45% Chemours -5.00% 60.64% 1.48%

Does the media prefer HUN or CC?

In the previous week, Chemours had 1 more articles in the media than Huntsman. MarketBeat recorded 19 mentions for Chemours and 18 mentions for Huntsman. Chemours' average media sentiment score of 0.47 beat Huntsman's score of -0.04 indicating that Chemours is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Huntsman 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has better valuation and earnings, NTR or CC?

Nutrien has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nutrien $26.89B 1.30 $2.27B $4.94 14.77 Chemours $5.81B 0.41 -$386M -$1.91 N/A

Is NTR or CC more profitable?

Nutrien has a net margin of 8.44% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Nutrien's return on equity. Company Net Margins Return on Equity Return on Assets Nutrien 8.44% 8.88% 4.27% Chemours -5.00% 60.64% 1.48%

Does the media refer more to NTR or CC?

In the previous week, Chemours had 10 more articles in the media than Nutrien. MarketBeat recorded 19 mentions for Chemours and 9 mentions for Nutrien. Nutrien's average media sentiment score of 1.74 beat Chemours' score of 0.47 indicating that Nutrien is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutrien 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Chemours 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, CC or OLN?

Olin has higher revenue and earnings than Chemours. Olin is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemours $5.81B 0.41 -$386M -$1.91 N/A Olin $6.78B 0.31 -$100.50M -$1.23 N/A

Is CC or OLN more profitable?

Olin has a net margin of -2.08% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Olin's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -5.00% 60.64% 1.48% Olin -2.08% -4.76% -1.17%

Does the media favor CC or OLN?

In the previous week, Chemours had 16 more articles in the media than Olin. MarketBeat recorded 19 mentions for Chemours and 3 mentions for Olin. Chemours' average media sentiment score of 0.47 beat Olin's score of 0.00 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Olin 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Chemours (CC) Competitors

$15.90 -0.01 (-0.06%)

As of 12:52 PM Eastern

Compare

CC vs. ASIX, EMN, HUN, NTR, and OLN

Should you buy Chemours stock or one of its competitors? Chemours's main competitors and comparable companies include AdvanSix (ASIX), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), and Olin (OLN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does Chemours compare to AdvanSix?

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, Chemours had 16 more articles in the media than AdvanSix. MarketBeat recorded 19 mentions for Chemours and 3 mentions for AdvanSix. Chemours' average media sentiment score of 0.47 beat AdvanSix's score of 0.11 indicating that Chemours is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
AdvanSix	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

AdvanSix has lower revenue, but higher earnings than Chemours. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.41	-$386M	-$1.91	N/A
AdvanSix	$1.52B	0.31	$49.29M	-$0.66	N/A

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.7%. Chemours pays out -18.3% of its earnings in the form of a dividend. AdvanSix pays out -97.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Chemours currently has a consensus target price of $20.10, indicating a potential upside of 26.42%. AdvanSix has a consensus target price of $21.50, indicating a potential upside of 24.42%. Given Chemours' stronger consensus rating and higher possible upside, research analysts plainly believe Chemours is more favorable than AdvanSix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

76.3% of Chemours shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 5.0% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Chemours has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, AdvanSix has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

AdvanSix has a net margin of -1.14% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-5.00%	60.64%	1.48%
AdvanSix	-1.14%	-1.28%	-0.61%

Summary

Chemours beats AdvanSix on 11 of the 19 factors compared between the two stocks.

How does Chemours compare to Eastman Chemical?

Eastman Chemical (NYSE:EMN) and Chemours (NYSE:CC) are both mid-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

83.7% of Eastman Chemical shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 2.6% of Eastman Chemical shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 4.5%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. Eastman Chemical pays out 87.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -18.3% of its earnings in the form of a dividend. Eastman Chemical has increased its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Eastman Chemical has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Chemours has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

Eastman Chemical has a net margin of 4.99% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eastman Chemical	4.99%	9.46%	3.78%
Chemours	-5.00%	60.64%	1.48%

In the previous week, Chemours had 1 more articles in the media than Eastman Chemical. MarketBeat recorded 19 mentions for Chemours and 18 mentions for Eastman Chemical. Eastman Chemical's average media sentiment score of 0.75 beat Chemours' score of 0.47 indicating that Eastman Chemical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eastman Chemical	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemours	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Eastman Chemical has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eastman Chemical	$8.87B	0.96	$474M	$3.84	19.32
Chemours	$5.81B	0.41	-$386M	-$1.91	N/A

Eastman Chemical presently has a consensus target price of $79.17, suggesting a potential upside of 6.69%. Chemours has a consensus target price of $20.10, suggesting a potential upside of 26.42%. Given Chemours' higher possible upside, analysts plainly believe Chemours is more favorable than Eastman Chemical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eastman Chemical	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Chemours	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Eastman Chemical beats Chemours on 14 of the 19 factors compared between the two stocks.

How does Chemours compare to Huntsman?

Huntsman (NYSE:HUN) and Chemours (NYSE:CC) are both materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Huntsman has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, Chemours has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Huntsman has higher earnings, but lower revenue than Chemours. Huntsman is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huntsman	$5.68B	0.31	-$284M	-$1.04	N/A
Chemours	$5.81B	0.41	-$386M	-$1.91	N/A

Huntsman pays an annual dividend of $0.35 per share and has a dividend yield of 3.4%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. Huntsman pays out -33.7% of its earnings in the form of a dividend. Chemours pays out -18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 4 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Chemours had 1 more articles in the media than Huntsman. MarketBeat recorded 19 mentions for Chemours and 18 mentions for Huntsman. Chemours' average media sentiment score of 0.47 beat Huntsman's score of -0.04 indicating that Chemours is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Huntsman	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemours	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Huntsman has a net margin of -3.05% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Huntsman's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huntsman	-3.05%	-3.49%	-1.45%
Chemours	-5.00%	60.64%	1.48%

Huntsman presently has a consensus target price of $12.50, indicating a potential upside of 23.15%. Chemours has a consensus target price of $20.10, indicating a potential upside of 26.42%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Huntsman.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huntsman	3 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
Chemours	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

84.8% of Huntsman shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 6.8% of Huntsman shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Chemours beats Huntsman on 11 of the 20 factors compared between the two stocks.

How does Chemours compare to Nutrien?

Nutrien (NYSE:NTR) and Chemours (NYSE:CC) are both materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.0%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. Nutrien pays out 44.5% of its earnings in the form of a dividend. Chemours pays out -18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nutrien has raised its dividend for 7 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Chemours had 10 more articles in the media than Nutrien. MarketBeat recorded 19 mentions for Chemours and 9 mentions for Nutrien. Nutrien's average media sentiment score of 1.74 beat Chemours' score of 0.47 indicating that Nutrien is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutrien	9 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Chemours	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Nutrien has a net margin of 8.44% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Nutrien's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutrien	8.44%	8.88%	4.27%
Chemours	-5.00%	60.64%	1.48%

Nutrien has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutrien	$26.89B	1.30	$2.27B	$4.94	14.77
Chemours	$5.81B	0.41	-$386M	-$1.91	N/A

Nutrien has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Chemours has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

Nutrien presently has a consensus target price of $81.58, indicating a potential upside of 11.78%. Chemours has a consensus target price of $20.10, indicating a potential upside of 26.42%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Nutrien.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutrien	1 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.76
Chemours	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

63.1% of Nutrien shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 3.1% of Nutrien shares are held by insiders. Comparatively, 0.9% of Chemours shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Nutrien beats Chemours on 13 of the 19 factors compared between the two stocks.

How does Chemours compare to Olin?

Chemours (NYSE:CC) and Olin (NYSE:OLN) are both mid-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Chemours currently has a consensus target price of $20.10, indicating a potential upside of 26.42%. Olin has a consensus target price of $23.08, indicating a potential upside of 24.14%. Given Chemours' stronger consensus rating and higher possible upside, equities analysts clearly believe Chemours is more favorable than Olin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
Olin	4 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.94

Chemours has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, Olin has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

In the previous week, Chemours had 16 more articles in the media than Olin. MarketBeat recorded 19 mentions for Chemours and 3 mentions for Olin. Chemours' average media sentiment score of 0.47 beat Olin's score of 0.00 indicating that Chemours is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Olin	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. Olin pays an annual dividend of $0.80 per share and has a dividend yield of 4.3%. Chemours pays out -18.3% of its earnings in the form of a dividend. Olin pays out -65.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Olin is clearly the better dividend stock, given its higher yield and lower payout ratio.

Olin has a net margin of -2.08% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Olin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-5.00%	60.64%	1.48%
Olin	-2.08%	-4.76%	-1.17%

76.3% of Chemours shares are held by institutional investors. Comparatively, 88.7% of Olin shares are held by institutional investors. 0.9% of Chemours shares are held by insiders. Comparatively, 1.6% of Olin shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Olin has higher revenue and earnings than Chemours. Olin is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.41	-$386M	-$1.91	N/A
Olin	$6.78B	0.31	-$100.50M	-$1.23	N/A

Summary

Chemours beats Olin on 10 of the 19 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CC vs. The Competition

Export

Metric	Chemours	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$2.39B	$11.42B	$4.99B	$24.17B
Dividend Yield	2.27%	2.87%	4.71%	3.72%
P/E Ratio	-8.32	39.90	26.67	30.09
Price / Sales	0.41	46.60	4,872.71	19.96
Price / Cash	4.68	15.28	26.99	31.97
Price / Book	-49.69	3.69	8.87	6.83
Net Income	-$386M	$222.46M	$154.79M	$1.07B
7 Day Performance	4.41%	0.11%	1.56%	-1.07%
1 Month Performance	-7.54%	3.07%	10.16%	2.45%
1 Year Performance	10.72%	21.17%	47.15%	17.58%

Chemours Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CC Chemours	4.505 of 5 stars	$15.90 -0.1%	$20.10 +26.4%	+5.9%	$2.39B	$5.81B	N/A	5,700	Analyst Revision
ASIX AdvanSix	3.8908 of 5 stars	$16.75 -1.7%	$21.50 +28.4%	-16.0%	$460.10M	$1.56B	N/A	1,410
EMN Eastman Chemical	4.8207 of 5 stars	$73.78 -0.4%	$79.17 +7.3%	+12.5%	$8.47B	$8.75B	19.21	13,000	Analyst Revision
HUN Huntsman	4.3704 of 5 stars	$10.32 +0.2%	$12.83 +24.4%	-0.1%	$1.81B	$5.68B	N/A	6,000	Analyst Forecast Analyst Revision
NTR Nutrien	4.8649 of 5 stars	$68.33 +0.1%	$81.58 +19.4%	+24.2%	$32.64B	$26.89B	13.83	25,100	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CC) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Competitors